Showing results (681-690 of 780) with videos related to
Sort By:
Pageof 78
Journal of the National Cancer Institute|April 18, 1990
Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trialR G Steis, L A VanderMolen, D L Longo, et al.Cancer Research|June 1, 1992
Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effectsC H Ewel, W J Urba, W C Kopp, et al.Medical Science Educator|August 5, 2024
Evaluation of an Educational Scholarship Fellowship Program for Health Professions EducatorsAmber J Heck, Sateesh Arja, Laura D Bauler, et al.Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
Integrin activation controls metastasis in human breast cancerB Felding-Habermann, T E O'Toole, J W Smith, et al.Neurology|September 10, 2009
Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathyH H Biswas, J W Engstrom, Z Kaidarova, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group studyK A Margolin, P Y Liu, L E Flaherty, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavityR G Steis, W J Urba, L A VanderMolen, et al.The New England Journal of Medicine|March 18, 1993
The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatinJ W Smith, D L Longo, W G Alvord, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignanciesJ W Smith, W J Urba, B D Curti, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|March 1, 1996
Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancerB D Curti, W J Urba, D L Longo, et al.Pageof 78